v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2026
Sep. 30, 2025
Current Assets:    
Cash and cash equivalents $ 2,632,634 $ 3,924,908
Accounts receivable, net of allowances 1,079,055
Inventory 22,659,590 22,286,693
Prepaid expenses 3,052,387 1,331,280
Total Current Assets 29,423,666 27,542,881
Other Assets:    
In-process research and development, net of accumulated amortization 71,106,250 73,400,000
Deferred financing costs 169,252
Total Other Assets 71,275,502 73,400,000
Total Assets 100,699,168 100,942,881
Current Liabilities:    
Accounts payable 8,883,239 13,234,684
License payable 17,650,000 22,650,000
Accrued expenses 24,057,573 4,093,124
Total Current Liabilities 58,812,298 49,491,579
Deferred tax liability 2,817,990 2,784,960
Total Liabilities 65,430,399 56,076,650
Stockholders’ Equity:    
Preferred stock - $0.0001 par value; 10,000,000 shares authorized: no shares issued and outstanding
Common stock - $0.0001 par value; 400,000,000 shares authorized at March 31, 2026 and September 30, 2025; 92,981,204 and 83,513,442 shares issued and outstanding at March 31, 2026 and September 30, 2025, respectively 9,298 8,351
Additional paid-in capital 131,443,191 108,897,836
Accumulated deficit (96,183,720) (64,039,956)
Total Stockholders’ Equity 35,268,769 44,866,231
Total Liabilities and Stockholders’ Equity 100,699,168 100,942,881
Related Party    
Current Liabilities:    
Due to related party 8,221,486 9,513,771
Note payable to related party $ 3,800,111 $ 3,800,111